Pharmaceutical
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Strength
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Pack Size
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Form
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Source
European Medicines Agency
Safety Profile
Contraindications
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Side Effects
Crysvita : Orphan Maintenance Assessment Report (II-0023)
Scan this QR code to access this page quickly on your mobile device.